7 Results for "

Ozagrel

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "Ozagrel" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-B0428
CAS No.: 82571-53-7
Synonyms: OKY-046
Ozagrel (OKY-046) is a high selective and orally active thromboxane A2 (TXA2) synthase inhibitor with an IC50 of 11 nM. Ozagrel exerts anti-platelet aggregation, vasodilation and anti-inflammatory effects by inhibiting the production of TXA2 and increasing the production of prostacyclin (PGI2). Ozagrel can be used for the study of ischemic stroke, asthma and thromboembolic diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B0428B
CAS No.: 78712-43-3
Synonyms: OKY-046 hydrochloride
Ozagrel hydrochloride (OKY-046 hydrochloride) is a high selective and orally active thromboxane A2 (TXA2) synthase inhibitor with an IC50 of 11 nM. Ozagrel hydrochloride exerts anti-platelet aggregation, vasodilation and anti-inflammatory effects by inhibiting the production of TXA2 and increasing the production of prostacyclin (PGI2). Ozagrel hydrochloride can be used for the study of ischemic stroke, asthma and thromboembolic diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B0428A
CAS No.: 189224-26-8
Synonyms: OKY-046 sodium
Ozagrel sodium (OKY-046 sodium) is a high selective and orally active thromboxane A2 (TXA2) synthase inhibitor with an IC50 of 11 nM. Ozagrel sodium exerts anti-platelet aggregation, vasodilation and anti-inflammatory effects by inhibiting the production of TXA2 and increasing the production of prostacyclin (PGI2). Ozagrel sodium can be used for the study of ischemic stroke, asthma and thromboembolic diseases .
loading...
    loading...
Cat. No.: HY-B0428BR
CAS No.: 78712-43-3
Synonyms: OKY-046 hydrochloride (Standard)
Ozagrel hydrochloride (Standard) is the analytical reference standard of Ozagrel hydrochloride (HY-B0428B). Ozagrel hydrochloride (OKY-046 hydrochloride) is a high selective and orally active thromboxane A2 (TXA2) synthase inhibitor with an IC50 of 11 nM. Ozagrel hydrochloride exerts anti-platelet aggregation, vasodilation and anti-inflammatory effects by inhibiting the production of TXA2 and increasing the production of prostacyclin (PGI2). Ozagrel hydrochloride can be used for the study of ischemic stroke, asthma and thromboembolic diseases .
loading...
    loading...
Cat. No.: HY-W004645
CAS No.: 866157-50-8
Target:  

Drug Intermediate

Research Areas:  

Others

Ozagrel methyl ester is a drug impurity.
loading...
    loading...
Cat. No.: HY-B0428D
CAS No.: 130952-46-4
Synonyms: (E/Z)-OKY-046 sodium
(E/Z)-Ozagrel sodium [(E/Z)-OKY-046 sodium] is an EZ configuration mixture of Ozagrel sodium (HY-B0428A). Ozagrel sodium (OKY-046 sodium) is a high selective and orally active thromboxane A2 (TXA2) synthase inhibitor with an IC50 of 11 nM. Ozagrel sodium exerts anti-platelet aggregation, vasodilation and anti-inflammatory effects by inhibiting the production of TXA2 and increasing the production of prostacyclin (PGI2). Ozagrel sodium can be used for the study of ischemic stroke, asthma and thromboembolic diseases .
loading...
    loading...
Cat. No.: HY-W004645R
CAS No.: 866157-50-8
Target:  

Reference Standards

(E)-methyl 3-(4-((1H-imidazol-1-yl)methyl)phenyl)acrylate (Standard) is the analytical standard of (E)-methyl 3-(4-((1H-imidazol-1-yl)methyl)phenyl)acrylate. This product is intended for research and analytical applications.
loading...
    loading...